These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 29974077)
1. Aberrant expression of ETS1 and ETS2 proteins in cancer. Fry EA; Inoue K Cancer Rep Rev; 2018; 2(3):. PubMed ID: 29974077 [TBL] [Abstract][Full Text] [Related]
2. Translocations involving ETS family proteins in human cancer. Fry EA; Mallakin A; Inoue K Integr Cancer Sci Ther; 2018 Aug; 5(4):. PubMed ID: 30542624 [TBL] [Abstract][Full Text] [Related]
3. Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2. Plotnik JP; Hollenhorst PC Nucleic Acids Res; 2017 May; 45(8):4452-4462. PubMed ID: 28119415 [TBL] [Abstract][Full Text] [Related]
4. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction. Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821 [TBL] [Abstract][Full Text] [Related]
5. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Yang BS; Hauser CA; Henkel G; Colman MS; Van Beveren C; Stacey KJ; Hume DA; Maki RA; Ostrowski MC Mol Cell Biol; 1996 Feb; 16(2):538-47. PubMed ID: 8552081 [TBL] [Abstract][Full Text] [Related]
6. The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1. Bosselut R; Duvall JF; Gégonne A; Bailly M; Hémar A; Brady J; Ghysdael J EMBO J; 1990 Oct; 9(10):3137-44. PubMed ID: 2209540 [TBL] [Abstract][Full Text] [Related]
7. ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques. Robinson L; Panayiotakis A; Papas TS; Kola I; Seth A Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7170-5. PubMed ID: 9207063 [TBL] [Abstract][Full Text] [Related]
8. Distinct Prognostic and Immunological Roles of ETS1 and ETS2: A Pan-Cancer Analysis. Ren Y; Chen B; Zhang M Biomed Res Int; 2023; 2023():4343350. PubMed ID: 36760475 [TBL] [Abstract][Full Text] [Related]
9. Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites. Vaughan CA; Deb SP; Deb S; Windle B Oncotarget; 2014 Jan; 5(2):417-27. PubMed ID: 24481480 [TBL] [Abstract][Full Text] [Related]
10. Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene. Pastorcic M; Das HK J Biol Chem; 2000 Nov; 275(45):34938-45. PubMed ID: 10942770 [TBL] [Abstract][Full Text] [Related]
11. Transcription factor Ets1, but not the closely related factor Ets2, inhibits antibody-secreting cell differentiation. John S; Russell L; Chin SS; Luo W; Oshima R; Garrett-Sinha LA Mol Cell Biol; 2014 Feb; 34(3):522-32. PubMed ID: 24277931 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation. Kabbout M; Dakhlallah D; Sharma S; Bronisz A; Srinivasan R; Piper M; Marsh CB; Ostrowski MC PLoS One; 2014; 9(6):e100693. PubMed ID: 24968297 [TBL] [Abstract][Full Text] [Related]
13. Ets transcription factors and targets in osteogenesis. Raouf A; Seth A Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1. Blumenthal SG; Aichele G; Wirth T; Czernilofsky AP; Nordheim A; Dittmer J J Biol Chem; 1999 Apr; 274(18):12910-6. PubMed ID: 10212281 [TBL] [Abstract][Full Text] [Related]
15. Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1. Bhat NK; Thompson CB; Lindsten T; June CH; Fujiwara S; Koizumi S; Fisher RJ; Papas TS Proc Natl Acad Sci U S A; 1990 May; 87(10):3723-7. PubMed ID: 2187191 [TBL] [Abstract][Full Text] [Related]
16. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene. Kopp JL; Wilder PJ; Desler M; Kim JH; Hou J; Nowling T; Rizzino A J Biol Chem; 2004 May; 279(19):19407-20. PubMed ID: 14976186 [TBL] [Abstract][Full Text] [Related]
17. Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Wei G; Srinivasan R; Cantemir-Stone CZ; Sharma SM; Santhanam R; Weinstein M; Muthusamy N; Man AK; Oshima RG; Leone G; Ostrowski MC Blood; 2009 Jul; 114(5):1123-30. PubMed ID: 19411629 [TBL] [Abstract][Full Text] [Related]
18. Influence of nucleotides flanking the ggaa core sequence on ets1 and ets2 DNA-binding activity and the mechanism of ets1 autoregulation. Ascione R; Thompson D; Thomas R; Panayiotakis A; Ramsay R; Tymms M; Kola I; Seth A Int J Oncol; 1992 Nov; 1(6):631-7. PubMed ID: 21584592 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products. Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472 [TBL] [Abstract][Full Text] [Related]
20. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. Seth A; Robinson L; Thompson DM; Watson DK; Papas TS Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]